TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

24 hedge funds and large institutions have $23.2M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 8 closing their positions.

Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
5
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.41M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.49M
3
BCM
3
Bridgeway Capital Management
Texas
$82K
4
NAS
4
Nicolet Advisory Services
Wisconsin
$49K
5
PAM
5
Panagora Asset Management
Massachusetts
$83K

Top Sellers

1
TI
1
Telemetry Investments
New York
$811K
2
AFM
2
Anson Funds Management
Texas
$0
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$0
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
– – -89,721 Closed
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
– – -43,449 Closed
Citadel Advisors
28
Citadel Advisors
Florida
– – -26,373 Closed
QF
29
QVT Financial
New York
– – -23,351 Closed
VF
30
Virtu Financial
New York
– – -18,233 Closed
Macquarie Group
31
Macquarie Group
Australia
– – -6,195 Closed
LTFS
32
Ladenburg Thalmann Financial Services
Florida
$0 300 – –
CFGS
33
Concourse Financial Group Securities
Alabama
– – – –
1
2